Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Vrinda Gote, Michael Ansong & Dhananjay Pal. (2020) Prodrugs and nanomicelles to overcome ocular barriers for drug penetration. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 885-906.
Read now
Read now
Maria Aurora Grimaudo, Silvia Pescina, Cristina Padula, Patrizia Santi, Angel Concheiro, Carmen Alvarez-Lorenzo & Sara Nicoli. (2019) Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics. Expert Opinion on Drug Delivery 16:4, pages 397-413.
Read now
Read now
Sahar Gooneh-Farahani, M. Reza Naimi-Jamal & Seyed Morteza Naghib. (2019) Stimuli-responsive graphene-incorporated multifunctional chitosan for drug delivery applications: a review. Expert Opinion on Drug Delivery 16:1, pages 79-99.
Read now
Read now
Candela Rodríguez-Pomar, Jesus Pintor, Basilio Colligris & Gonzalo Carracedo. (2017) Therapeutic inhibitors for the treatment of dry eye syndrome. Expert Opinion on Pharmacotherapy 18:17, pages 1855-1865.
Read now
Read now
Fengzhen Wang, Li Chen, Dongsheng Zhang, Sunmin Jiang, Kun Shi, Yuan Huang, Rui Li & Qunwei Xu. (2014) Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study. Journal of Drug Targeting 22:9, pages 849-858.
Read now
Read now
Ebru Başaran & Yasemin Yazan. (2012) Ocular application of chitosan. Expert Opinion on Drug Delivery 9:6, pages 701-712.
Read now
Read now
Hye-Young Lee, Young-IL Jeong & Ki-Choon Choi. (2011) Hair dye-incorporated poly-γ-glutamic acid/glycol chitosan nanoparticles based on ion-complex formation. International Journal of Nanomedicine 6, pages 2879-2888.
Read now
Read now
Articles from other publishers (48)
Xiaomin Huang, Luoyuan Li, Zhongxing Chen, Haoyu Yu, Xinru You, Na Kong, Wei Tao, Xingtao Zhou & Jinhai Huang. (2023) Nanomedicine for the Detection and Treatment of Ocular Bacterial Infections. Advanced Materials 35:46.
Crossref
Crossref
Xuelin Tang, Jianhong Liu, Ruijiao Yan & Qiang Peng. (2023) Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review. International Journal of Biological Macromolecules 242, pages 124902.
Crossref
Crossref
Chuhan Wang & Yan Pang. (2023) Nano-based eye drop: Topical and noninvasive therapy for ocular diseases. Advanced Drug Delivery Reviews 194, pages 114721.
Crossref
Crossref
Prakriti Diwan, Rajendra Jangde, Sulekha Khunte, Harish Bhardwaj & Preeti K. Suresh. 2022. Drug Development Life Cycle. Drug Development Life Cycle.
Ilker S. Bayer. (2022) Recent Advances in Mucoadhesive Interface Materials, Mucoadhesion Characterization, and Technologies. Advanced Materials Interfaces 9:18, pages 2200211.
Crossref
Crossref
Ahmed Alaa Kassem, Abeer Salama & Amira Mohamed Mohsen. (2022) Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: In vitro and in vivo assessments. Journal of Drug Delivery Science and Technology 68, pages 103047.
Crossref
Crossref
Emily Dosmar, Julia Walsh, Michael Doyel, Katlynn Bussett, Adekite Oladipupo, Sabri Amer & Katherine Goebel. (2022) Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches. Bioengineering 9:1, pages 41.
Crossref
Crossref
Onyinye J. Uwaezuoke, Pradeep Kumar, Viness Pillay & Yahya E. Choonara. (2021) Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design. Drug Delivery and Translational Research 11:5, pages 1903-1923.
Crossref
Crossref
Wenjie Fan, Haijie Han, Yaoyao Chen, Xiaobo Zhang, Yifan Gao, Su Li, Qiao Jin, Jian Ji & Ke Yao. (2021) Antimicrobial nanomedicine for ocular bacterial and fungal infection. Drug Delivery and Translational Research 11:4, pages 1352-1375.
Crossref
Crossref
Jagpreet kour, Neha Kumari & Bharti Sapra. (2021) Ocular prodrugs: Attributes and challenges. Asian Journal of Pharmaceutical Sciences 16:2, pages 175-191.
Crossref
Crossref
Deepa Patel, Drashti Pathak & Praful Giradkar. 2021. Nanocarriers: Drug Delivery System. Nanocarriers: Drug Delivery System
457
483
.
Hussein M. Eid, Mohammed H. Elkomy, Shahira F. El Menshawe & Heba F. Salem. (2019) Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and Chitosan Coating. AAPS PharmSciTech 20:5.
Crossref
Crossref
Pooja Maharjan, Kwan Hyung Cho, Anjila Maharjan, Meong Cheol Shin, Cheol Moon & Kyoung Ah Min. (2018) Pharmaceutical challenges and perspectives in developing ophthalmic drug formulations. Journal of Pharmaceutical Investigation 49:2, pages 215-228.
Crossref
Crossref
Musaed Alkholief, Hammam Albasit, Adel Alhowyan, Sultan Alshehri, Mohammad Raish, Mohd Abul Kalam & Aws Alshamsan. (2019) Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir. Saudi Pharmaceutical Journal 27:2, pages 293-302.
Crossref
Crossref
Yuanhui Song, Nobuhiro Nagai, Saaya Saijo, Hirokazu Kaji, Matsuhiko Nishizawa & Toshiaki Abe. (2018) In situ formation of injectable chitosan-gelatin hydrogels through double crosslinking for sustained intraocular drug delivery. Materials Science and Engineering: C 88, pages 1-12.
Crossref
Crossref
Zhaoliang Zhang, Jing Yu, Yanfang Zhou, Renshu Zhang, Qianqian Song, Lei Lei & Xingyi Li. (2018) Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery. Colloids and Surfaces B: Biointerfaces 164, pages 436-443.
Crossref
Crossref
Yawei Chen, Wenjing Song, Xuan Zhao, Qianqian Han & Li Ren. (2018) An antibacterial collagen membrane crosslinked by the inclusion complex of β-cyclodextrin dialdehyde and ofloxacin for bacterial keratitis. RSC Advances 8:32, pages 18153-18162.
Crossref
Crossref
Kamla Pathak, Satyanarayan Pattnaik & Kalpana Swain. 2018. Nanoemulsions. Nanoemulsions
415
433
.
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2017. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis
139
172
.
A. Samanta, K. Merrett, M. Gerasimov & M. Griffith. 2017. Bioresorbable Polymers for Biomedical Applications. Bioresorbable Polymers for Biomedical Applications
497
523
.
Reena V. Saini & Reena Kumari. 2017. Metabolic Engineering for Bioactive Compounds. Metabolic Engineering for Bioactive Compounds
319
329
.
Vibhuti Agrahari, Abhirup Mandal, Vivek Agrahari, Hoang M. Trinh, Mary Joseph, Animikh Ray, Hicheme Hadji, Ranjana Mitra, Dhananjay Pal & Ashim K. Mitra. (2016) A comprehensive insight on ocular pharmacokinetics. Drug Delivery and Translational Research 6:6, pages 735-754.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2016) Cationorm? (cationic emulsion eye drops) in dry eye disease: a guide to its use. Drugs & Therapy Perspectives 32:8, pages 317-322.
Crossref
Crossref
Frances Lasowski & Heather Sheardown. (2016) Atropine and Roscovitine Release from Model Silicone Hydrogels. Optometry and Vision Science 93:4, pages 404-411.
Crossref
Crossref
Jaleh Barar, Ayuob Aghanejad, Marziyeh Fathi & Yadollah Omidi. (2016) Advanced drug delivery and targeting technologies for the ocular diseases. BioImpacts 6:1, pages 49-67.
Crossref
Crossref
Zhaoliang Zhang, Zhifen He, Renlong Liang, Yi Ma, Wenjuan Huang, Rou Jiang, Shuai Shi, Hao Chen & Xingyi Li. (2016) Fabrication of a Micellar Supramolecular Hydrogel for Ocular Drug Delivery. Biomacromolecules 17:3, pages 798-807.
Crossref
Crossref
Anthony Attama, Charles Lovelyn & Ebele Onuigbo. 2016. Nanotechnology and Drug Delivery, Volume Two. Nanotechnology and Drug Delivery, Volume Two
165
190
.
Shengyan Liu, Lyndon W. Jones & Frank X. Gu. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery
83
109
.
Viness Pillay, Yahya E. Choonara & Lisa C. du Toit. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery
407
460
.
Shuai Shi, Zhaoliang Zhang, Zichao Luo, Jing Yu, Renlong Liang, Xingyi Li & Hao Chen. (2015) Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac. Scientific Reports 5:1.
Crossref
Crossref
Shengyan Liu, Chu Ning Chang, Mohit S. Verma, Denise Hileeto, Alex Muntz, Ulrike Stahl, Jill Woods, Lyndon W. Jones & Frank X. Gu. (2014) Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome. Nano Research 8:2, pages 621-635.
Crossref
Crossref
Philippe Daull, Frédéric Lallemand & Jean-Sébastien Garrigue. (2014) Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. Journal of Pharmacy and Pharmacology 66:4, pages 531-541.
Crossref
Crossref
O’Rese J. Knight & Scott D. Lawrence. (2014) Sustained drug delivery in glaucoma. Current Opinion in Ophthalmology 25:2, pages 112-117.
Crossref
Crossref
Farhan Ahmad, Sohail Akhter, Mohammad Ahmad, Farshad Ramazani, Mohammad Samim, Musarrat Warsi, Mohammad Anwar & Ziyaur Rahman. 2013. Chitin and Chitosan Derivatives. Chitin and Chitosan Derivatives
317
336
.
Frank BoehmFrank Boehm. 2013. Nanomedical Device and Systems Design. Nanomedical Device and Systems Design
653
742
.
Peng Chen, Hao Chen, Xinjie Zang, Min Chen, Haoran Jiang, Shasha Han & Xianggen Wu. (2013) Expression of Efflux Transporters in Human Ocular Tissues. Drug Metabolism and Disposition 41:11, pages 1934-1948.
Crossref
Crossref
Lisa C. Du Toit, Thirumala Govender, Trevor Carmichael, Pradeep Kumar, Yahya E. Choonara & Viness Pillay. (2013) Design of an Anti-Inflammatory Composite Nanosystem and Evaluation of Its Potential for Ocular Drug Delivery. Journal of Pharmaceutical Sciences 102:8, pages 2780-2805.
Crossref
Crossref
Arun Kumar, Heidi Mansour, Adam Friedman & Eric BloughJaleh Barar & Yadollah Omidi. 2013. Nanomedicine in Drug Delivery. Nanomedicine in Drug Delivery
287
336
.
Wanachat ChaiyasanSangly P. SrinivasWaree Tiyaboonchai. (2013) Mucoadhesive Chitosan–Dextran Sulfate Nanoparticles for Sustained Drug Delivery to the Ocular Surface. Journal of Ocular Pharmacology and Therapeutics 29:2, pages 200-207.
Crossref
Crossref
Teresa Musumeci, Claudio Bucolo, Claudia Carbone, Rosario Pignatello, Filippo Drago & Giovanni Puglisi. (2013) Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. International Journal of Pharmaceutics 440:2, pages 135-140.
Crossref
Crossref
R. Herrero-Vanrell, M. Vicario de la Torre, V. Andrés-Guerrero, D. Barbosa-Alfaro, I.T. Molina-Martínez & I. Bravo-Osuna. (2013) Nano and microtechnologies for ophthalmic administration, an overview. Journal of Drug Delivery Science and Technology 23:2, pages 75-102.
Crossref
Crossref
Shengyan Liu, Lyndon Jones & Frank X. Gu. (2012)
Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(
D
,
L
-lactide)-
b
-Dextran Nanoparticles
. Macromolecular Bioscience 12:12, pages 1622-1626.
Crossref
Crossref
Kang Zhang, Liangfang Zhang & Robert N. Weinreb. (2012) Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nature Reviews Drug Discovery 11:7, pages 541-559.
Crossref
Crossref
Shengyan Liu, Lyndon Jones & Frank X. Gu. (2012) Nanomaterials for Ocular Drug Delivery. Macromolecular Bioscience 12:5, pages 608-620.
Crossref
Crossref
Frederic Lallemand, Philippe Daull, Simon Benita, Ronald Buggage & Jean-Sebastien Garrigue. (2012) Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb. Journal of Drug Delivery 2012, pages 1-16.
Crossref
Crossref
Elke Cario. (2011) Nanotechnology-based drug delivery in mucosal immune diseases: hype or hope?. Mucosal Immunology 5:1, pages 2-3.
Crossref
Crossref
Divya Seth & Farah I. Khan. (2011) Causes and Management of Red Eye in Pediatric Ophthalmology. Current Allergy and Asthma Reports 11:3, pages 212-219.
Crossref
Crossref
Jorge L. Jacot & David Sherris. (2011) Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy. Journal of Ophthalmology 2011, pages 1-19.
Crossref
Crossref